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Background. This study was done to characterize parameters associated with semen human immunodeficiency virus (HIV)-1 
ribonucleic acid (RNA) viral load (VL) variability in HIV-infected, therapy-naive men.
Methods. Paired blood and semen samples were collected from 30 HIV-infected, therapy-naive men who have sex with men, 
and 13 participants were observed longitudinally for up to 1 year. Human immunodeficiency virus RNA, bacterial load by 16S RNA, 
herpesvirus (Epstein-Barr virus and cytomegalovirus [CMV]) shedding, and semen cytokines/chemokines were quantified, and 
semen T-cell subsets were assessed by multiparameter flow cytometry.
Results. Semen HIV RNA was detected at 93% of visits, with >50% of men shedding high levels of virus (defined as >5000 
copies/mL). In the baseline cross-sectional analysis, an increased semen HIV VL correlated with local CMV reactivation, the semen 
bacterial load, and semen inflammatory cytokines, particularly interleukin (IL)-8. T cells in semen were more activated than blood, 
and there was an increased frequency of Th17 cells and γδ-T-cells. Subsequent prospective analysis demonstrated striking interindi-
vidual variability in HIV and CMV shedding patterns, and only semen IL-8 levels and the blood VL were independently associated 
with semen HIV levels.
Conclusions. Several clinical and immune parameters were associated with increased HIV semen levels in antiretroviral thera-
py-naive men, with induction of local proinflammatory cytokines potentially acting as a common pathway.
Keywords. cytokines; herpesviruses; HIV; microbiome; semen.
 
Semen containing human immunodeficiency virus (HIV)-1 is 
the major vector worldwide for transmission from an HIV-
infected, antiretroviral therapy (ART)-naive man to his sexual 
partner(s). Although the blood HIV ribonucleic acid (RNA) 
level is perhaps the best-defined predictor of transmission, 
with the annual transmission risk in HIV serodiscordant 
couples increasing from 0 to 25% as blood viral load (bVL) 
increases from undetectable levels to >50 000 HIV-1 RNA 
copies/mL [1], this reflects in part the correlation between 
bVL and semen VL (sVL) [2]. In keeping with this, the sVL of 
a male partner was an even stronger independent predictor of 
HIV transmission than the bVL, with each log10 sVL increase 
being associated with a 1.8-fold increased HIV transmission 
risk [2].
There can be substantial variability in the sVL, independ-
ent of the bVL, and at any given time they are moderately cor-
related at best [3]. Genital infections are an important cause 
of this variability, with acute Neisseria gonorrhoeae urethritis 
increasing the sVL almost 10-fold without any effect on bVL 
[4]. However, approximately one third of ART-naive men 
demonstrate levels of HIV RNA in semen that are dispropor-
tionately higher than those in blood, even in the absence of 
symptomatic urethritis or asymptomatic classic sexually trans-
mitted infections (STIs) [8]. Compartmentalized reactivation 
of asymptomatic, persistent human herpesviruses (HHVs), 
such as CMV and Epstein-Barr virus (EBV), have been linked 
with an elevated sVL [5–9], and the association of a dispro-
portionately high sVL with increased unprotected insertive 
(but not receptive) sex suggests that nonclassic STI may also 
be involved [10]. Associations are also seen between the sVL of 
ART-naive men and total semen bacterial levels (one aspect of 
the semen microbiome) [11, 12], several semen proinflamma-
tory cytokines [9, 13–15], and the presence of various immune 
cell subsets [15–17].
Effective ART dramatically reduces both the sVL and the 
probability of HIV transmission [18, 19]. However, many 
M A J O R  A R T I C L E
© The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases 
Society of America. This is an Open Access article distributed under the terms of the Creative 
Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/
by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any 
medium, provided the original work is not altered or transformed in any way, and that the work 
is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
DOI: 10.1093/ofid/ofx033
Received 13 December 2016; editorial decision 30 January 2017; accepted 14 February 2017.
Correspondence: B. J. W. Osborne, PhD, MBiotech, HBSc, Department of Medicine, #6356 
Medical Sciences Building, University of Toronto, Toronto, Ontario, Canada M5S1A8 (brendan-
jwosborne@gmail.com).
2 • OFID • Osborne et al
HIV-infected men in the world do not know their status 
and/or do not have access to ART, and so understanding the 
factors that cause variability in the sVL of ART-naive men 
remains an important priority, and this may lead to novel 
avenues for HIV prevention. Our goal in this study was to 
perform a comprehensive assessment in ART-naive men who 
have sex with men of several clinical and mucosal param-
eters that have previously been associated with HIV RNA 
shedding, to define independent predictors of increased 
HIV sVL, and to assess prospective patterns of HIV semen 
shedding.
METHODS
Study Participants and Design
Men who have sex with men infected with HIV for ≥1  year 
were recruited through the Maple Leaf Medical Clinic, Toronto 
between 2011 and 2013. Participants were ART naive and were 
screened for STIs at each study visit. All participants provided 
paired blood and semen samples at a single time point, and a 
subgroup of men who opted to defer ART provided monthly 
semen and blood samples for up to 1  year. All participants 
provided informed, written consent; ethical approval for this 
study was obtained through the research ethics board of the 
University of Toronto.
Sample Collection and Diagnostic Testing
Blood was collected into acid citrate dextran, and semen was 
collected by masturbation directly into a sterile container con-
taining 10  mL of Roswell Park Memorial Institute (RPMI) 
medium with penicillin/streptomycin after 48 hours of absti-
nence [20]. Samples were processed within 2 hours of col-
lection. Semen plasma (SP) was isolated by centrifugation at 
850 × g for 10 minutes, and blood plasma (BP) was isolated after 
Ficoll density gradient centrifugation at 500 × g for 25 minutes. 
Blood plasma and SP HIV RNA VL were assayed using the 
Abbott RealTime HIV-1 assay using an automated m2000 sys-
tem (Abbott Molecular Diagnostics). Due to occasional spillage 
of RPMI medium during semen collection and/or sample trans-
port, correction for semen dilution assumed a semen volume of 
2 mL, as previously validated [20]. The lower limit of detection 
for bVL and sVL were 50 and 300 HIV RNA copies/mL, respec-
tively. High-level semen shedding was defined as a VL >5000 
HIV RNA copes/mL [1].
Real-Time Quantification of Semen Herpesvirus Levels
Viral load quantification of herpes simplex virus (HSV)-1, 
HSV-2, HHV-3, EBV, CMV, HHV-7, and HHV-8 was per-
formed by reverse transcription-polymerase chain reaction 
(PCR) using the genesig quantitative PCR (qPCR) detection 
kit (PrimerDesign Ltd); HHV-6 A-B was quantified using the 
RealStar PCR kit (Altona Diagnostics) [21]. In brief, deoxyrib-
onucleic acid (DNA) was extracted from 400 μL of SP using a 
DNA mini extraction kit (QIAGEN, Inc., Valencia, CA). For the 
genesig kits, extracted SP DNA (5 μL) containing the provided 
internal control was combined with a PCR mix containing 10 
μL 2×Precision MasterMix, 1 μL Primer/Probe mix, and 4 μL 
RNAse/DNAse-free water. For the RealStar PCR kit, 10 μL of 
extracted SP DNA was added to the mastermix containing 5 μL 
of master-A, 15 μL of master-B, and 1 μL of the internal control. 
All viruses were quantified using the Applied Biosystems 7900 
HT Real-Time PCR system with the after reactions conditions: 
95°C for 10 minutes followed by 50 cycles of 95°C for 10 sec-
onds (genesig) or 15 minutes (RealStar) and 60°C for 1 minute. 
Results were analyzed using the Sequence Detection System, 
version 2.4 (Applied Biosystems). Lower limit of detection was 
200 copies/mL.
Cytokine and Trappin-2/Elafin Levels in Semen Plasma
Cytokine levels in SP were measured using the Meso Scale 
Discovery multiplex System (Gaithersburg, MD). Fourteen 
cytokines/chemokines were measured (lower limit of quan-
tification listed in parenthesis): interleukin (IL)-1α (3.6 
pg/mL), IL-6 (3.6 pg/mL), IL-1β (3.6 pg/mL), IL-8 (1.8 pg/
mL), monocyte chemoattractant protein (MCP)-1 (1.8 pg/
mL), macrophage-derived chemokine ([MDC] 1.8 pg/mL), 
monokine induced by interferon-γ ([MIG] 1.8 pg/mL), mac-
rophage inflammatory protein (MIP)-1β (29.28 pg/mL), 
MIP-3α (14.64 pg/mL), regulated on activation, normal T cells 
expressed and secreted ([RANTES] 3.6 pg/mL), IL-10 (1.8 pg/
mL), IL-17 (3.6 pg/mL), interferon-inducible protein (IP)-10 
(14.64), and tumor necrosis factor (TNF)-α (1.8 pg/mL). All 
samples were run in duplicate according to the manufacturer’s 
protocol. For cytokine levels below the lower limit of detection 
of the assay, values were reported as the lower limit of quan-
tification based on the standard curve. Commercially avail-
able Trappin-2/Elafin enzyme-linked immunosorbent assay 
kits (Hycult Biotech) were used to measure SP levels of Elafin 
according to manufacturer’s instructions. The levels of many 
cytokines coassociate in semen, and so to reduce concerns 
around multiple comparisons we calculated a semen inflam-
mation (SI) score: this was based on prior work in the female 
genital tract (FGT) [22], with slight modification to accom-
modate FGT-semen cytokine differences. Men who had 4 or 
more of 9 inflammatory cytokines (TNF-α, IL-1α, IL-1β, IL-6, 
IL-8, IL-17, MIP-3α, IL-1β, and MIP-1β) in the upper quartile 
were defined as inflamed, and the total number of cytokines 
in the upper quartile constituted an inflammation score (from 
0 to 9).
Bacterial Load Quantification
For bacterial load quantification, 500 μL of thawed SP was lysed 
using a combination of chemical and mechanical methods 
and purified using AllPrep DNA/RNA Mini Kit (QIAGEN). 
Deoxyribonucleic acid was eluted in 100  μL of buffer EB, 
whereas RNA was eluted in 50  μL. Reverse transcription was 
performed using qScript cDNA SuperMix according to the 
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manufacturer’s instructions (Quanta Biosciences, Gaithersburg, 
MD). Using the DNA fraction, bacterial load was quantfied, 
measured as bacterial 16S recombinant RNA (rRNA) gene 
copy/mL of SP using a broad-coverage qPCR assay, described 
previously [23].
T-Cell Populations in Blood and Semen
Mononuclear cells were stained for 30 minutes with fluoro-
chrome-labeled monoclonal antibodies (CD3G-FITC, CD8-
PETR, CD195-PerCPCy5.5, CD69-PECy7, β7integrin-APC, 
HLADR-APCH7, CD196-Pacific Blue, CD3-605NC, CD4-
650NC) and a viability dye (Invitrogen) followed by fixation 
for 30 minutes in 1% paraformaldehyde and analyzed using BD 
LSR-II (BD Systems).
Statistical Analysis
Flow cytometry analysis was performed using FlowJo analyti-
cal software, version 9.4.11 (Tree Star). Non-parametric Mann-
Whitney U and Wilcoxon signed-rank analysis were performed 
using IBM SPSS Statistics, version 20 (IBM Corporation). 
Backward stepwise linear regression analyses were performed 
for multiple independent covariants using SPSS, with P < .05 
as the threshold for significance. Count and/or concentration 
variables were logarithmically transformed. For longitudinal 
multivariate analysis, a mixed model (MM) analysis was used 
to take into account multiple observations/measurements pro-
duced per individuals within the study. Variables associated 
with the outcome variable on univariate analysis (P < .1) were 
selected for the multivariable analysis.
RESULTS
Cross-Sectional Cohort Demographics and Viral Loads
Thirty HIV-infected, antiretroviral-naive men provided paired 
blood and semen samples. All participants were infected with 
HIV for at least 1  year (median, 3  years; range, 1–23  years). 
Study participants had median absolute CD4 and CD8 T-cell 
counts of 440 cells/mm3 (range, 190–860) and 905 cells/mm3 
(range, 230–2690), respectively. The median bVL was 30 544 
HIV-1 RNA copies/mL (range, 824 to >500 000 copies/mL), 
and median sVL was 5496 HIV-1 RNA copies/mL (range, 300–
208 152 copies/mL). All study participants were CMV sero-
positive, 80% (24 of 30) HSV-1 seropositive, and 33.3% (10 of 
30) HSV-2 seropositive. Clinical parameters are summarized in 
Table 1.
Semen HIV RNA was detected in 93% (28 of 30) of partic-
ipants, and 50% (15 of 30)  met criteria for high-level semen 
shedding with an sVL ≥5000 copies of HIV-1 RNA/mL. 
Two individuals had asymptomatic urethral infection with 
Chlamydia trachomatis: both had high-level semen shedding 
and elevated semen cytokines and T-cell populations, and these 
individuals were removed from subsequent analysis. In 10.7% 
(3 of 28)  of men, the sVL exceeded the paired bVL, meeting 
predefined criteria for disproportionately high HIV-1 semen 
shedding. At baseline, there was a weak correlation between 
blood and semen VL (r = 0.26; P =  .160). Viral load data are 
summarized in Table 1.
Semen Cytokines and the Semen Viral Load
Levels of 14 cytokine/chemokines (see Methods) and of Elafin/
Trappin-2 were assayed in SP (Table 2). Semen inflammation, 
defined as ≥4 of 9 proinflammatory cytokines in the top quar-
tile for that cytokine (see above), was present in 6 of 28 (21%) 
participants, and it was strongly associated with HIV semen 
shedding (median sVL 4.89 log10 HIV RNA copies/mL for men 
Table 1.  Clinical Demographics of Study Participants
Parameter
Cross-Sectional Cohort
(n = 30)
Age 34 (range, 24–56)
Years infecteda 3 (IQR, 1–4)
HSV-1 80% (24/30)
HSV-2 33.3% (10/30)
HSV1+/HSV2+ 26.7% (8/30)
HSV1−/HSV2− 13.3% (4/30)
CMV 100% (30/30)
Absolute CD4a 440 (190–860)
Absolute CD8a 905 (230–2690)
CD4/CD8 ratioa 0.56 (0.17–1.97)
Blood viral load (copies/mL) 30 544 (824–500 000)
Semen viral load (copies/mL) 5496 (300–208 152)
Semen bacterial load (16s copies/mL) 379 252 (19 672–12 736 702)
Semen CMV viral load (copies/mL) 282 (200–266 761)
Semen EBV viral load (copies/mL) 200 (200–409 156)
Abbreviations: CMV, cytomegalovirus; EBV, Epstein-Barr virus; HSV, herpes simplex virus; 
IQR, interquartile range.
aMedian values reported.
Table 2.  Seminal Plasma Cytokine and Chemokine Levels
Cytokine/  
Protein
Median 
(pg/mL)
Percent  
Detectable (%)
Range  
(pg/mL)
IL-1α 139 100% 12–1135
IL-8 1451 100% 176–180 408
MCP-1 3378 100% 289–79 593
MDC 26 034 100% 2298–127 178
MIG 33 511 100% 2939–114 179
MIP-3α 1167 93% 30–3769
RANTES 373 100% 25–1935
IL-10 49 82% 15–188
IL-17 37 82% 15–190
IL-1β 47 64% 24–592
IL-6 119 100% 14–3866
IP-10 35 768 100% 4019–222 383
MIP-1β 251 68% 90–7216
TNF-α 8.9 82% 1.8–96
Trappin-2 1871 100% 839–7823
Abbreviations: IL, interleukin; IP, interferon-gamma-induced protein; MCP, monocyte che-
moattractant protein; MDC, macrophage-derived chemokine; MIG, monokine induced by 
interferon-γ; MIP, macrophage inflammatory protein; RANTES, regulated on activation, nor-
mal T cells expressed and secreted; TNF, tumor necrosis factor. Bolded percentage was to 
show cytokine/chemokine levels that were not detected in 100% of participants.
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with SI vs 3.42 without; MW P = .008) (Figure 1). Furthermore, 
an inflammation score that was calculated as the number 
of these cytokines in the top quartile (range, 0–9) was also 
strongly correlated with the sVL (Spearman correlation coeffi-
cient P = .65; P < .001). Subsequent analysis demonstrated that 
the sVL was positively associated with semen levels of IL-1α 
(P = .009), IL-8 (P = .033), IL-1β (P = .005), IL-6 (P = .037), and 
MIP-1β (P = .031). To determine the strongest cytokine corre-
lates of sVL, a partial correlation analysis controlling for bVL 
was performed. After controlling for bVL, semen levels of IL-8 
(P = .002), IL-1α (P = .024), IL-1β (P = .011), IL-6 (P = .013), 
and MIP-1β (P =  .006) remained significantly correlated with 
the sVL. The independent association(s) of these individual 
cytokines with the sVL was then assessed in a stepwise multi-
variate linear regression model, with IL-8 (P < .001) emerging 
as the strongest independent cytokine correlate of the sVL, fol-
lowed by IL-1β (P = .03) (Figure 1). Trappin-2/Elafin was read-
ily detectable in SP, but levels did not correlate with either the 
sVL or semen cytokine/chemokine levels.
The Semen Viral Load and Local Herpesvirus Reactivation
Herpesvirus qPCR was performed on all semen samples; 63% 
(19 of 30) passed internal control standards for CMV and 67% 
(20 of 30) for EBV. Internal control/run failure for the remain-
ing samples may be due to the presence of PCR inhibitors, a 
common issue with qPCR assays in SP [24]. Cytomegalovirus 
was detected in the SP of 11 of 19 (58%), and EBV was detected 
in 6 of 20 (30%) participants; median CMV and EBV VL were 
486 copies CMV DNA/mL (range, 200–266 761) and 200 copies 
EBV DNA/mL (range, 200–409 157), respectively. Semen HSV-
1, HSV-2, HHV-3, HHV-7, and HHV-8 were undetectable in 
all patients, and HHV6 was only detected at very low levels in 
the semen of 2 participants. Therefore, subsequent analysis was 
focused on CMV and EBV.
Semen levels of CMV but not EBV correlated with the HIV 
sVL (P  =  .014 and P  =  .511, respectively (Figure  2). Semen 
CMV levels tended to be higher in men with SI (median 4.40 
vs 2.38 log10 DNA copies/mL; MW P = .063) and were directly 
correlated with the inflammation score (Spearman’s rho = 0.64; 
P = .006), whereas EBV levels were not related with either the 
presence or degree of inflammation. In particular, CMV levels 
correlated with semen cytokines IL-10 (0.048), IL-1β (<0.001), 
IL-6 (0.009), MIP-1β (0.004), and TNF-α (0.006). The inde-
pendent association of these cytokines with semen CMV VL 
was assessed in a stepwise multivariate linear regression model 
with semen IL-1β level (P < .001) correlating most strongly with 
CMV VL.
Semen T-Cell Immune Parameters and the Semen Viral Load 
Semen mononuclear cells (SMCs) were analyzed by flow cytom-
etry in the subset of men (13 of 30; 43.3%) who consented to be 
observed longitudinally, to evaluate the prospective associations 
of T-cell phenotype and activation status with sVL. Ninety-
three semen samples (approximately 7 samples per participant) 
were collected, and for practical reasons flow cytometry was 
performed on 76 of these samples (82%): adequate semen T-cell 
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Figure 1. Association of semen human immunodeficiency virus (HIV) viral load 
with local inflammation and proinflammatory cytokines. Levels of semen HIV RNA in 
antiretroviral therapy-naive men were strongly associated with both the presence/
absence of semen inflammation (top panel), based on modification of a previously 
defined mucosal algorithm, and with levels of individual proinflammatory cytokines 
(bottom 2 panels; interleukin [IL]-8 and IL-1β shown).
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numbers (above our cutoff of ≥50 cell events) were present 
for CD4+ T-cell analysis in 69 of 76 (91%) and for CD8+ T-cell 
analysis in 73 of 76 (96%). Semen T cells were immunologically 
much more activated than those in the blood of the same par-
ticipant. In particular, coexpression of CD38 and HLA-DR was 
higher on both semen CD4+ T cells (median, 16.25% vs 0.89%; 
P < .001) and CD8+ T cells (median, 13.75% vs 3.91%; P = .039), 
as was the early activation/TRM marker CD69 on both CD4
+ 
(32.80% vs 3.14%; P < .001) and CD8+ (57.0 vs 5.17; P < .001) 
T cells. Semen CD4+ T cells also expressed higher levels of the 
HIV coreceptor CCR5 (24.15% vs 4.3%; P <  .001) and of the 
Th17 marker CCR6 (28.8 vs 4.3; P = .003), whereas expression 
of β7, a proxy for the mucosal homing integrin α4β7
+, was lower 
on semen CD4+ T cells (0.9% vs 2.1%; P = .013). The proportion 
of CD3+ T cells expressing the gamma-delta receptor (CD3G) 
tended to be higher in peripheral blood mononuclear cells than 
SMCs (2.84 vs 0.94; P = .180), although semen CD3G+ T cells 
expressed higher levels of CCR6 (83.7 vs 0.43; P < .001).
Overall, CD4+ and CD8+ T-cell numbers in the semen 
were strongly correlated with a number of immune and viro-
logic semen parameters, including the CMV VL (Spearman 
rho = 0.78 and 0.89, both P < .01) and the SI score (Spearman 
rho = 0.77 and 0.85, both P < .001), and less strongly with the 
semen HIV VL (Spearman rho  =  0.48 and 0.64, P  =  .11 and 
P  =  .02, respectively). No T-cell associations were seen with 
semen levels of EBV or with the semen bacterial load (see 
below).
Bacterial Load in Semen and the Semen Viral Load 
To broadly assess whether the endogenous microbiome of the 
semen compartment [25] impacted semen immunology and 
sVL, total bacterial load was quantified by 16S rRNA. In men 
free of bacterial STIs, the total bacterial load was positively cor-
related with both the HIV sVL (Spearman rho = 0.51; P = .016) 
(Figure 3) and the SI score (Spearman rho = 0.48; P = .024), and 
it was higher in participants meeting criteria for SI (median 
log10 bacterial load 7.03 vs 5.40; P = .003). Furthermore, the bac-
terial load was significantly correlated with semen levels of the 
individual cytokines IL-8 (P = .004), MCP-1 (P = .022), MDC 
(P = .017), MIP-3α (P = .008), IL-6 (P = .012), IP-10 (P = .007), 
and TNF-α (0.046). However, no association of the bacterial 
load was observed with baseline clinical parameters or the local 
reactivation of CMV or EBV.
Longitudinal Cohort Demographics
A subgroup of participants (n = 13) provided monthly, paired 
semen and blood samples for up to 12 months, or until initi-
ation of ART, to permit assessment of sVL and semen immu-
nology changes within an individual. Herpes simplex virus-1 
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Figure 2. Reactivation of semen herepesviruses and the semen HIV viral load. Semen HIV RNA levels in ARV-Naive men were associated with levels of (A) semen CMV 
DNA (left) but not (B) semen EBV DNA (right).
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Figure 3. Association of 16s rRNA bacterial load with semen HIV-1 RNA lev-
els. The total concentration of bacterial 16s rRNA, a crude marker of the semen 
microbiome, was positively correlated with semen HIV RNA levels in antiretroviral 
therapy-naive men.
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and HSV-2 seroprevalence was 92% (12 of 13) and 46% (6 of 
13), respectively, and the median duration of follow-up was 
7 months (range, 2–12 months) with a total of 93 sample visits 
(an average of just over 7 visits per participant).
Patterns and Correlates of Human Immunodeficiency Virus Shedding 
in Semen
High-level semen shedding (>5000 copies/mL) had been 
detected at enrollment in 45.5% (5 of 11) of the STI-free pro-
spective participants: during follow up, high-level shedding was 
detected at 1 study visit or more in 69% (9 of 13) and overall at 
51.6% (48 of 93) of study visits. The median sVL was 0.95 log10 
(0.79-fold) lower than the bVL (median bVL 4.45 log10 copies/
mL, range 2.92–5.18 log10 copies/mL vs median sVL 3.50 log10 
copies/mL, range 2.48–5.00 log10 copies/mL), but there was sub-
stantial inter-individual variability. In approximately half of the 
participants, the sVL was consistently lower than the blood (6 of 
13 participants; representative example) (Figure 4A). Although 
only 23% (3 of 13)  of study men had an undetectable sVL at 
any time point, 1 individual maintained an undetectable sVL at 
each of 9 study visits despite a median bVL of 3.69 log10 copies/
mL (range, 3.06–3.87 log10 copies/mL) (Figure 4B). One partic-
ipant (1 of 13) consistently demonstrated a disproportionately 
high sVL (Figure 4C), whereas in the remaining 6 of 13 partici-
pants, the sVL was sometimes lower than blood and sometimes 
disproportionately high (Figure 4D). In addition, the variability 
in semen versus blood HIV-1 RNA levels was assessed by cal-
culating the ratio and variance of log10 semen/log10 blood RNA 
levels (Table  3). Although the median semen/blood VL ratio 
was 0.87, it exceeded 1 in 2 participants (15%), and there was 
considerable heterogeneity in the variance of this ratio, ranging 
from 0.002 to 0.149.
Longitudinal Correlates of Human Immunodeficiency Virus Shedding 
in Semen
Semen parameters that had been associated with the sVL in the 
cross-sectional analysis also varied over time. Cytomegalovirus 
reactivation was more common than EBV in semen, with detec-
tion in 9 of 13 vs 4 of 13 participants at any time point, and at 
29.0% (27 of 93) vs 7.5% (7 of 93) of total study visits, respec-
tively. The median semen CMV VL was 241 copies/mL (range, 
200–266 761 copies/mL) and exceeded 5000 copies/mL dur-
ing 29.6% (8 of 27) reactivations; the median semen EBV VL 
was also 200 copies/mL (range, 200–353 125 copies/mL) and 
exceeded 5000 copies/mL during 28.6% (2 of 7) reactivations. 
Semen flow cytometry assays were performed for 76 of 93 sam-
ples collected, and sufficient (>50 cells per sample) semen CD4+ 
T cells for analysis were present in 69 of 76 (90.1%) samples and 
CD8+ T cells in 73 of 76 (96.1%) samples. In general, the semen 
bacterial load, semen cytokine levels, and T-cell parameters 
were relatively stable over time (data not shown).
Finally, a multivariable MM that incorporated the longitu-
dinal viral, immune, and bacterial load data was then used to 
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Figure 4. Longitudinal patterns of HIV RNA semen shedding over time in antiret-
roviral therapy-naive men. Examples of semen HIV RNA semen shedding patterns 
over time: (a) blood viral load (VL) consistently higher than semen; (b) persistently 
undetectable semen HIV RNA VL; (c) sustained disproportionate HIV semen shed-
ding; (d) intermittent disproportionate HIV semen shedding. blood plasma; semen 
plasma.
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assess independent associations of the HIV sVL (see Methods). 
In this prospective analysis, the only independent associations 
of HIV sVL were the bVL (P <  .001) and semen levels of the 
proinflammatory chemokine IL-8 (P  <  .001). For every log10 
unit increase in bVL, the sVL increased by 0.40 log10, and for 
every log10 increase in the IL-8, the sVL increased by 0.75 log10. 
In this prospective analysis, the semen to blood HIV VL ratio, 
which was calculated to assess the contribution of individual 
semen parameters to the local HIV VL, was most strongly asso-
ciated with semen IL-8 levels (P < .001) (Figure 5).
DISCUSSION
The semen of an HIV-infected, ART-naive man is the vector for 
most global HIV transmission, with the HIV RNA VL in both 
blood and semen being independent predictors of HIV trans-
mission risk [2]. Although the semen HIV RNA VL is generally 
lower than that in blood, virus levels in the semen compart-
ment are more variable [26–28], and a subset of men manifest 
disproportionately high levels of HIV in semen [8, 10, 29] with 
an increased sVL linked to STIs, herpesvirus reactivation, and 
local immune activation [4–6, 30]. Prior studies have often 
been cross-sectional and focused on individual semen param-
eters, and it is not clear whether patterns of differential HIV 
shedding are stable in an individual over time. Therefore, the 
current study prospectively assessed the association of multiple 
semen parameters with the sVL in ART-naive men, to define 
independent associations. Factors associated with the HIV 
RNA sVL in univariate analysis included the blood VL, semen 
CMV reactivation, levels of proinflammatory cytokines and 
chemokines, the total bacterial load, and semen T-cell numbers. 
However, there was substantial inter-individual and intra-indi-
vidual variability in the patterns of HIV semen shedding over 
time, and the only independent associations of semen HIV 
RNA levels were the bVL and semen levels of the proinflam-
matory chemokine IL-8, suggesting that the latter may consti-
tute an inflammatory biomarker that links heterogeneous local 
causes of increased HIV RNA shedding in semen.
Interleukin-8 is a proinflammatory cytokine produced by 
a variety of cells, particularly macrophages/monocytes [31]. 
Macrophages constitute 20%–30% of white blood cells in semen, 
and they are almost 10-fold more common than T-lymphocytes 
(2%–5%) [32]. Not only are increased semen levels of IL-8 seen 
in the context of HIV infection, but IL-8 also increases HIV 
replication in cervical explant tissue models, and competitive 
inhibition of the IL-8 receptor CXCR2 decreases explant HIV 
susceptibility by 45%–70% [33]. Although our study demon-
strates that IL-8 is an important local correlate of semen HIV 
levels, it is not known whether the relationship is causal or 
whether IL-8 serves as a biomarker for an additional, unmeas-
ured factor associated with SI. Future studies should confirm 
the cellular origin of IL-8 and assess the ability of therapeutic 
strategies targeting IL-8 to reduce semen HIV levels.
Although several of the “upstream” mucosal parameters 
associated with the sVL had been previously described, oth-
ers were novel. Local reactivation of CMV has been previ-
ously associated with the sVL [9, 30], and increased semen 
cytokines have been associated with semen levels of both 
CMV and HIV [8, 34, 35]. The absolute number of HIV-
specific T cells in semen has also been associated with the 
sVL [8], although this was not seen in studies where a sub-
stantial proportion of men were on ART [34]. However, 
the novel finding of an association between the total semen 
bacterial load and the sVL in the absence of classic STIs 
strongly suggests that the semen microbiome plays a role in 
HIV transmission, an area for future research. The fact that 
local CMV reactivation, the semen bacterial load, and semen 
Table 3. Prospective Variability in the Semen/Blood HIV RNA Viral Load Ratio
Patient ID Log10 sVL/Log10 bVL
a No. of Visits Variance Minimum Maximum
001 0.903 8 0.005 0.80 1.02
002 1.373 7 0.017 1.25 1.64
003 1.130 9 0.149 0.87 2.19
004 0.772 9 0.002 0.68 0.80
005 0.797 5 0.010 0.66 0.90
006 0.943 10 0.011 0.73 1.03
007 0.970 2 0.046 0.82 1.12
008 0.940 10 0.012 0.82 1.13
009 0.671 7 0.054 0.53 1.16
010 0.671 9 0.002 0.64 0.81
011 0.887 2 0.002 0.85 0.92
012 0.824 7 0.033 0.69 1.20
013 0.873 8 0.013 0.62 0.97
All visits 0.873 93 0.062 0.53 2.19
Abbreviations: bVL, blood viral load; HIV, human immunodeficiency virus; ID, identification; RNA, ribonucleic acid; sVL, semen viral load. 
aMedian values reported
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T-cell numbers were all associated with semen proinflamma-
tory cytokines, and that semen IL-8 levels were the only local 
(semen) parameter independently associated with the sVL on 
multivariate analysis, suggests that IL-8 might serve as a final 
common pathway for an increased sVL.
There was considerable inter-individual heterogeneity in 
patterns of semen HIV shedding. The sVL has generally been 
observed to be significantly lower than the bVL [36, 37], and, 
on average, that was also the case in our study. However, we 
found that less than half of all participants consistently had 
an sVL lower than the bVL, whereas a slight majority (>53%) 
either consistently or intermittently demonstrated a dispropor-
tionately high sVL. This variability has implications for predict-
ing HIV transmission at an individual level, and it stresses the 
importance of prospective studies. However, it is important to 
note that the early initiation of ART is now the norm in devel-
oped countries [38], both for the health benefits provided to 
the HIV-infected person and to reduce HIV transmission. The 
impact of effective ART on the sVL will supercede the param-
eters that we studied, because ART rapidly reduces the sVL 
to undetectable levels in most men [19, 27, 39–41]. However, 
because many people infected by HIV globally are unable to 
access therapy, it is still important to study HIV semen shed-
ding in ART-naive men.
The sample size was limited in the current study, particu-
larly for the prospective analysis of semen shedding, in large 
part because ART is now recommended for all HIV-infected 
men. Despite this, our prospective analysis of the relationship 
between the sVL and multiple semen parameters provides 
new insights of public health importance. In particular, the 
prospective cohort component clearly confirmed the bVL to 
be a strong predictor of semen HIV levels, as has been previ-
ously described, while adding semen IL-8 levels as a strong, 
independent mucosal (compartmentalized) predictor. Semen 
VLs were calculated based on an assumed volume of 2  mL, 
due to relatively frequent spillage of collection medium during 
sample collection and transport. Because there is inter-individ-
ual heterogeneity in semen volume, this will have led to some 
imprecision in our calculation of sVL and semen cytokine con-
centrations, but in prior studies this assumption did not affect 
the outcome of analyses based on these parameters [12, 20]. 
Mixed models and generalized estimating equations (GEE) 
are both statistical approaches to deal with correlated observa-
tions; GEE deals with marginal (ie, population level) models, 
and MM deals with conditional models. These approaches may 
provide slightly different results in nonlinear models, but for 
linear models (such as were used in this analysis), the 2 meth-
ods/models are practically identical for the random intercept 
models, and MM was used in this case to enable multilevel, 
random slope models.
CONCLUSIONS
In summary, our study confirms considerable variability in 
the sVL among HIV-infected, ART-naive men, and patterns of 
shedding vary considerably over time. Fluctuation in the sVL 
is not only dependent on the bVL, but it is also associated with 
multiple compartmentalized factors in semen, including T-cell 
influx, herpesvirus reactivation, and the microbiome, with 
effects on the sVL mediated through increased local levels of 
proinflammatory cytokines, particularly IL-8.
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